Foley Named a Top 50 Construction Law Firm by Construction Executive
23 June 2020
Construction Executive
Construction Executive magazine named Foley to its 2020 list of Top 50 Construction Law Firms in the United States in its second annual rankings of law firms.
Construction Executive’s methodology for its Top 50 Construction Law Firms rankings included asking hundreds of U.S. construction law firms to complete a survey. The data collected included: 1) 2019 revenues from the firm’s construction practice; 2) number of attorneys in the firm’s construction practice; 3) percentage of firm’s total revenues derived from its construction practice; 4) number of states in which the firm is licensed to practice; 5) year in which the construction practice was established; and 6) The number of AEC clients served during fiscal year 2019. The ranking was determined by an algorithm that weighted the aforementioned factors in descending order of importance.
Read the rankings and related story here.
Construction Executive’s methodology for its Top 50 Construction Law Firms rankings included asking hundreds of U.S. construction law firms to complete a survey. The data collected included: 1) 2019 revenues from the firm’s construction practice; 2) number of attorneys in the firm’s construction practice; 3) percentage of firm’s total revenues derived from its construction practice; 4) number of states in which the firm is licensed to practice; 5) year in which the construction practice was established; and 6) The number of AEC clients served during fiscal year 2019. The ranking was determined by an algorithm that weighted the aforementioned factors in descending order of importance.
Read the rankings and related story here.
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."